Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug–gene interaction networks analysis

Lung cancer is the most common cancer in men and women. This cancer is divided into two main types, namely non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Around 85 to 90 percent of lung cancers are NSCLC. Repositioning potent candidate drugs in NSCLC treatment is one of the im...

Descripción completa

Detalles Bibliográficos
Autores principales: MotieGhader, Habib, Tabrizi-Nezhadi, Parinaz, Deldar Abad Paskeh, Mahshid, Baradaran, Behzad, Mokhtarzadeh, Ahad, Hashemi, Mehrdad, Lanjanian, Hossein, Jazayeri, Seyed Mehdi, Maleki, Masoud, Khodadadi, Ehsan, Nematzadeh, Sajjad, Kiani, Farzad, Maghsoudloo, Mazaher, Masoudi-Nejad, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177601/
https://www.ncbi.nlm.nih.gov/pubmed/35676421
http://dx.doi.org/10.1038/s41598-022-13719-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177601/
https://www.ncbi.nlm.nih.gov/pubmed/35676421
http://dx.doi.org/10.1038/s41598-022-13719-8

Ejemplares similares